Daniel A. Carestio is the President and Chief Executive Officer of STERIS, a leading global provider of products and services focused on infection prevention, decontamination, and surgical and critical care technologies. With a strong background in the healthcare and medical device industries, Carestio has been instrumental in steering STERIS towards continued growth and innovation. He joined STERIS in 2012 as the Vice President and General Manager of the company's Healthcare Products division, where he quickly demonstrated his leadership and strategic vision. Prior to his tenure at STERIS, Carestio held various leadership positions at renowned companies such as Johnson & Johnson and Boston Scientific. His experience in these roles equipped him with a deep understanding of the medical device market and the needs of healthcare providers worldwide. Under his leadership as President and CEO since 2018, STERIS has expanded its global footprint, strengthened its product portfolio, and maintained a strong commitment to quality and customer service. Carestio's strategic initiatives have included key acquisitions that have enhanced STERIS's capabilities and market position. As the head of STERIS, Daniel A. Carestio is responsible for overseeing the company's overall operations and strategic direction. He works closely with the board of directors and executive team to set long-term goals and ensure the company remains at the forefront of the industry. Carestio's leadership style emphasizes collaboration, innovation, and a relentless focus on improving patient outcomes. His vision for STERIS is to continue to be a trusted partner for healthcare providers, delivering solutions that enhance safety, efficiency, and quality of care.